abstract BACKGROUND AND OBJECTIVES: Polysomnography defines the pathophysiology of obstructive sleep apnea syndrome (OSAS) but does not predict some important comorbidities or their response to adenotonsillectomy. We assessed whether OSAS symptoms, as reflected on the Sleep-Related Breathing Disorders Scale of the Pediatric Sleep Questionnaire (PSQ), may offer clinical predictive value.
WHAT'S KNOWN ON THIS SUBJECT:
Obstructive sleep apnea syndrome (OSAS) is associated with significant comorbidity: behavioral problems, sleepiness, and impaired quality of life. However, the utility of OSAS symptoms versus polysomnography in the prediction of comorbidities or response to treatment is not well known.
WHAT THIS STUDY ADDS:
Among children with OSAS, the Pediatric Sleep Questionnaire, a wellvalidated, simple 1-page symptom inventory, predicts key adenotonsillectomy-responsive OSAS comorbidities and their improvement after adenotonsillectomy. In contrast, polysomnographic results do not offer similar predictive value.
Obstructive sleep apnea syndrome (OSAS) is a common disorder in childhood and can result in a range of adverse health outcomes. In children, adenotonsillar hypertrophy is the most common cause of OSAS, and adenotonsillectomy is the most common treatment. 1, 2 In clinical research, OSAS is defined in large part by objective sleep laboratory-based polysomnography (PSG) measurements. However, multiple previous efforts to show clinically useful associations between PSG findings and important comorbidities, or their response to adenotonsillectomy, have been disappointing. [3] [4] [5] [6] [7] [8] [9] [10] In clinical practice, differences exist between medical professional societies as to whether PSG should be obtained to assess OSAS before adenotonsillectomy. Practice guidelines from the American Academy of Sleep Medicine and American Academy of Pediatrics recommend PSG to confirm and characterize OSAS before adenotonsillectomy, 1, 2, 11 whereas the American Academy of Otolaryngology-Head and Neck Surgery recommends PSG for children with certain complex medical conditions or when there is discordance between tonsil size and reported severity of OSAS symptoms. 12 Less work has been done to define what adjunctive measures, in addition to PSG, may assist pediatricians, otolaryngologists, and families who are considering adenotonsillectomy to understand what adverse impact OSAS is having for the child and what the probability is that this adverse impact will be ameliorated by surgery. For example, few studies have examined whether baseline OSAS symptoms can predict postoperative changes in parentperceived behavior, sleepiness, and quality of life, outcomes that assume key importance to families, regardless of PSG results. One study reported that preoperative OSAS symptoms predicted OSAS-related neurobehavioral morbidity, and its response to adenotonsillectomy, as well as or better than did PSG findings. 13 Since then, a large multicenter, randomized clinical trial, the Childhood Adenotonsillectomy (CHAT) study, found that OSAS treatment improves key subjectively assessed health outcomes (behavior, sleepiness, symptoms, and quality of life) but not objective cognitive measures. 10 Data from the surgical arm of this study offer an ideal opportunity to assess more definitively whether OSAS symptoms, as reflected by a well-validated symptom inventory, the Sleep-Related Breathing Disorders Scale of the Pediatric Sleep Questionnaire (PSQ), 14 provide clinical utility beyond the PSG in assessment of concurrent OSAS-related comorbidities, specifically neurobehavioral problems, sleepiness, and quality of life. We also assess the extent to which the PSQ scale may provide incremental value in prediction of OSAS-related, treatment-responsive outcomes after adenotonsillectomy.
METHODS

Study Design, Setting, and Population
Details of the CHAT study design have been published. 10, 15 In brief, habitually snoring 5-to 9-year-old children who were candidates for adenotonsillectomy were recruited from otolaryngology practices, pediatric sleep clinics, and other sources at 6 US medical centers for this prospective, randomized, controlled, single-blind trial. The key inclusion criterion was PSGconfirmed OSAS with an obstructive apnea/hypopnea index (AHI) $2 events per hour or an obstructive apnea index (OAI) $1. Key exclusion criteria were AHI .30, OAI .20, oxygen saturation ,90% for $2% of total sleep time, recurrent tonsillitis, BMI z score $3, or medication for attention-deficit/hyperactivity disorder. Institutional review board approval was obtained at each site. Written informed consent from 1 parent and assent from each child age $7 years were obtained.
Outcomes
Outcomes in these analyses were selected to reflect the primary outcome variable in CHAT (the Developmental Neuropsychological Assessment [NEPSY-A/E], a cognitive measure that was shown not to be responsive to surgery) and the other key outcome measures that did prove responsive to adenotonsillectomy. Selected measures included an objective measure of attention and executive functioning (NEPSY-A/E), validated neurobehavioral rating scales, global and disease-specific measures of quality of life, and sleepiness. The NEPSY-A/E generates scores ranging from 50 to 150, with 100 representing the population mean and higher scores indicating better functioning. 16 Neurobehavioral assessments included caregiver ratings of executive functioning on the Behavior Rating Inventory of Executive Function (BRIEF) global executive composite score (scores range from 28 to 101), with higher scores indicating worse functioning 17 ; attention on the Conners' Rating Scale Revised: Long Version Global Index (T scores range from 38 to 90), with higher scores indicating worse functioning 18 ; and behavior on the Child Behavior Checklist (CBCL) total score (mean T-scores = 50, SD = 10), with higher scores indicating worse behaviors. 19 We assessed global quality of life with both parent and child ratings on the Pediatric Quality of Life Inventory (PedsQL), in which scores range from 0 to 100 and higher scores indicate better quality of life. 20 We assessed disease-specific quality of life by using the 18-item Obstructive Sleep Apnea-18 (OSAS-18) assessment tool, a composite of OSAS-related symptoms and quality of life in which scores range from 18 to 126, with higher scores indicating worse quality of life. 21 We assessed sleepiness by using the Epworth Sleepiness Scale (ESS), modified for children, in which scores range from 0 to 24, with higher scores indicating greater daytime sleepiness. 7 
Predictors
PSG
Details about the PSG protocol are available in the online supplement that accompanied the primary outcome paper. 10 In brief, children underwent full, in-laboratory PSG performed by study-certified technicians according to a standardized protocol, with similar sensors, and according to American Academy of Sleep Medicine guidelines for acquisition and pediatric scoring. 22 
Statistical Analyses
Spearman's correlation coefficients were used to summarize the unadjusted associations between baseline PSG or PSQ measures and baseline comorbidity measures or their improvement after adenotonsillectomy. The strength of the correlations was categorized as large (.0.5), moderate (0.3-0.5), small (0.1-0.3), or insubstantial (,0.1). 24 The potential PSQ and PSG predictor variables were reduced to those most strongly correlated with behavioral health measures. Multivariable logistic regression models were used to assess the extent to which the total PSQ scale and AHI at baseline independently predicted morbidity measures at baseline or their improvement across 7 months. Each participant's morbidity score at baseline was dichotomized based on whether it was $0.5 SD worse than the mean. Each participant's outcome measure change score was dichotomized based on whether improvement was $0.5 SD from that participant's baseline. The predictor variable (PSQ or AHI) was normalized so that the odds ratio (OR) in each model reflected the effect on the given morbidity measure of a 1-SD increase in the predictor variable, equivalent to 0.18 points on the PSQ or 5.8 points in the AHI. The c-statistic was used to assess goodness of fit. Values for this measure range from 0.5 to 1. A value of 0.5 indicates that the model is no better than chance, and a value of 1.0 indicates that the model perfectly identifies those within a group and those not. All models were adjusted for age, race, gender, and BMI z score. The level of significance was set at .05 and not adjusted for multiple comparisons. Analyses were performed with a statistical software program (SAS version 9.2; SAS Institute Inc, Cary, NC).
RESULTS
Analyses are restricted to the 185 participants (94% of the 196) with complete PSQ and PSG data at baseline and postadenotonsillectomy visits (Fig 2) . Baseline characteristics, PSG data, and PSQ scores are summarized in Table 1 . The mean PSQ score was 0.48 6 0.18, and 142 (77%) had a positive PSQ total score $0.33. Table 2 summarizes the OSAS comorbidity measures, all of which improved significantly after adenotonsillectomy. Table 3 summarizes the associations of the baseline PSQ total score with various PSG measures at baseline and at follow-up. After adenotonsillectomy, the median (interquartile range [IQR]) AHI change from baseline to 7 months was 23.5 (6.1), and 79% of the participants "normalized," that is, had an AHI ,2 and OAI ,1. The mean PSQ change from baseline to 7 months was 20.3 6 0.2, and 148 (80%) of the PSQ total scores were ,0.33. Baseline PSQ scores were significantly associated with AHI and the ODI 3% at both baseline and follow-up but were not associated with higher ETCO 2 values or other PSG measures.
Correlations Between Baseline PSQ or PSG and Behavioral Health Measures, Sleepiness, and Quality of Life at Baseline and Follow-up Overall, these bivariate comparisons indicate that the strongest PSG correlate of impairment of baseline scores and improvement after adenotonsillectomy was the AHI, and the best PSQ predictor was the total score. Table 4 shows correlations between the baseline PSQ scales or PSG variables and baseline morbidity measures. Of the various PSQ scale scores, the PSQ total score showed the most consistent and strongest correlations with the study's behavioral, sleepiness, and quality of life metrics. The largest correlations were seen for parent ratings of executive function, attention, behavior, and disease-specific quality of life. Comparing the correlation coefficients for different PSQ subscales (snoring, sleepiness, inattention and hyperactivity) helped identify which components of the PSQ scale contributed most to the associations between the full PSQ scale and various health outcomes. For example, the PSQ inattention and hyperactivity subscale showed large and significant correlations with parent rating scales for executive function, attention, and behavior. In contrast to the PSQ, PSG measures had fewer significant correlations with these symptom and behavioral measures. The AHI and ODI 3% showed a small correlation with disease-specific quality of life. Of the other sleep measures, a higher percentage of stage N3 showed a small correlation with parent ratings of more problems in executive functioning, attention, and behavior, the inverse of what might be expected. Less REM sleep showed a small correlation with worse
FIGURE 1
Items and response options for the Sleep-Disordered Breathing Scale of the PSQ. 14 Copyright © 2000 The Regents of the University of Michigan. The Sleep-Related Breathing Disorder Scale of the PSQ can be licensed and obtained without charge online at http://inventions.umich.edu/technologies/3773/ sleep-related-breathing-disorder-scale-srbd-scale-from-pediatric-sleep-questionnaire-to-identifysymptoms-of-obstructive-sleep-apnea-in-children.
FIGURE 2
Detailed information about the study flow.
disease-specific quality of life. Table 5 shows the correlations between baseline PSG or PSQ results and health outcomes after adenotonsillectomy. Outcome measures showed associations that were similar in direction and magnitude to those generated by the baseline health measures: many moderate to high correlations between PSQ and study outcomes, with fewer and lower-magnitude correlations between PSG and the outcomes.
Logistic Regression of Baseline Morbidity Measures or Their
Improvement at Follow-up on Baseline PSG or PSG Results Table 6 shows the results of multivariable logistic regression models in which baseline AHI and PSQ total score, adjusted for age, race, gender, and BMI z score, were evaluated as predictors of impaired health status at baseline. Even after adjustment for baseline AHI, the PSQ total score was strongly predictive of impaired behavioral health, including parent ratings of more problems in executive function (OR 3.2), attention (OR 4.2), and behavior (OR 3.1); lower parent-rated global quality of life (OR 2.5) and disease-specific quality of life (OR 5.7); lower childrated global quality of life (1.6); and more sleepiness (OR 1.8). In contrast, the AHI showed no independent associations with these study metrics after adjustment for baseline PSQ total score. Neither the PSQ total score nor AHI predicted lower objectively measured attention and executive function. Table 7 shows results from adjusted multivariable logistic regressions of improved health outcomes (by at least 0.5 SD) at 7 months on baseline PSQ and AHI. The baseline PSQ total score remained independently predictive of improvement in parent ratings of executive function, attention, behavior, global quality of Our study confirms the findings from a single-center study 13 The major strengths of this study are that data were prospectively collected from a large, well-characterized, multicenter sample of children with PSG-proven OSAS, and selected study outcomes represented a range of important OSAS-related health outcomes (neurobehavioral morbidity, sleepiness, and quality of life) that proved responsive to adenotonsillectomy. 10 Data collection was rigorously standardized with high levels of quality control.
Limitations include a study design that excluded more severely affected children (3.5% of those screened) with higher apnea hypopnea indices or sustained hypoxemia, in whom PSG data may have been a better predictor of health outcomes. 10 Conversely, the CHAT study also excluded 49% of otherwise eligible children who proved to have very low AHI values. The PSQ range was also restricted because all participants had to snore and be operative candidates, so the low range of scores was not captured. The study included a restricted age range that could have limited capture of the full disease burden of OSAS. Because parents in the adenotonsillectomy arm of CHAT were not blinded, the experience of the surgery may have influenced their ratings of improved outcomes. However, the stronger associations of the PSQ versus PSG data with baseline OSAS-related morbidities before randomization would not have Logistic regression adjusted for age, gender, race, and BMI z score. PSQ score and AHI normalized to model the effect of a 1-SD increase (equivalent to 0.18 points on the PSQ or 5.8 points for the AHI), after adjustment for the baseline value of the other predictor and other covariates in the model. a Clinically meaningful impairment defined for this analysis as a morbidity score $0.5 SD worse than baseline mean.
been affected. Analyses were not adjusted for multiple comparisons, and there was no intention to provide a prediction equation for clinical use. Finally, we did not look at outcomes outside the very broad metric of neurologic issues, such as growth, cardiovascular, metabolic, and operative risks, which are all very important.
Our data do not support the use of the PSQ as a replacement for the PSG, nor do they support the sole use of either the PSG or PSQ for making individual treatment decisions. Notably, despite the significant associations of PSQ total scores with tested comorbidities and postsurgical improvements, the c-statistics for all models (PSQ or PSG or combined) were low to moderate. In this study, only 77% of habitually snoring children with PSG-confirmed OSAS had "positive" PSQ scores. In a previous study of children scheduled for adenotonsillectomy, the PSQ had a sensitivity of 78% and a specificity of 72% for PSG-defined OSAS, 13 with 74% of participants classified accurately. To the extent that the PSQ does not show results identical to those of the PSG, our data suggest that the discrepancy may offer an opportunity to improve some aspects of clinical care rather than an invalid assessment to be disregarded when PSG data are available.
CONCLUSIONS
The On page e666, in Table 2 , for the NEPSY-A/E score row, the column data for Baseline, Follow-up, Change From Baseline, and Effect Size were incorrect. The correct data are shown in the accompanying table.
On page e668, in Table 5 , the Spearman correlation coefficient data in the NEPSY A/E column were incorrect. The correct data are shown in the accompanying table.
On page e669, in Table 7 , the logistic regression data in the Higher NEPSY-AE row for PSG and AHI were incorrect. The correct data are shown in the accompanying Logistic regression adjusted for age, gender, race, BMI z score. PSG and AHI normalized to reflect the effect of a 1 SD increase (equivalent to 0.18 points on the PSQ or 5.8 points in the AHI), after adjustment for the baseline value of the other predictor and other covariates in the model. a Clinically meaningful improvement defined as an improvement in the morbidity measure by $0.5 SD from its baseline mean.
